FITM is a highly potent and selective negative allosteric modulator of the metabotropic glutamate receptor 1 (mGlu1), exhibiting a Ki of 2.5 nM. This small molecule is a valuable research tool for investigating mGlu1 function in neurological disorders, with applications in both in vitro binding assays and in vivo pharmacological studies.